NRIX
NASDAQ · Biotechnology
Nurix Therapeutics Inc
$15.15
+0.31 (+2.09%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+377.2% upside
Low Target
$45.76
Average Target
$72.29
High Target
$82.91
Current Price
$15.15
Current
$15.15
$15.15
Target
$72.29
$72.29
$45.76
$72.29 avg
$82.91
Scenario Analysis
Bear Case
$45.76
202.0%
Low target
Base Case
$72.29
+377.2%
Avg target
Bull Case
$82.91
+447.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$28.23
-46.3% from high
52-Week Low
$11.67
+29.8% from low
Target vs 52W High
$72.29
+156.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |